Michelle Teplensky
Assistant Professor (BME, MSE)
2026 REU Project: Modifying Nanocarriers to Modulate Release From Hydrogel
Research in the Teplensky Lab focuses on engineering nanotechnology to control immunological cell connectivity, processing, and communication by design. In doing so, we elucidate fundamentals about cellular events and leverage this knowledge to develop improved therapeutics and vaccines that can impact the treatment of cancer and infectious disease.
Dr. Teplensky’s work is highly interdisciplinary, and bridges the fields of engineering, chemistry, nanotechnology, immunology, and biomaterials. enabling the lab to develop and incorporate synthetic nanoscale advances to control immunological activity and elucidate design rules that have widespread impacts on therapeutic development.
Previous REU/RET Projects include:
- Targeted Therapeutic Delivery through Modified Nanocarriers (REU, 2025)
- Departments
- Biomedical Engineering and Materials Science Engineering
- Affiliation
- Faculty
- Program Year
- 2025
- Fields
- Faculty and PI